NCT03202537View on ClinicalTrials.gov

Effectiveness of Physiologic Testing in PPI Non-Responders

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions
Gastro Esophageal Reflux
Interventions
DRUG

dexlansoprazole

dexlansoprazole treatment for Gastroesophageal Reflux symptoms

Trial Locations (1)

60611

Northwestern Memorial Health Care, Chicago

All Listed Sponsors
collaborator

Washington University School of Medicine

OTHER

collaborator

Vanderbilt University

OTHER

lead

Northwestern University

OTHER

NCT03202537 - Effectiveness of Physiologic Testing in PPI Non-Responders | Biotech Hunter | Biotech Hunter